Weikai Hou

718 total citations
19 papers, 575 citations indexed

About

Weikai Hou is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Weikai Hou has authored 19 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Weikai Hou's work include Metabolism, Diabetes, and Cancer (5 papers), Pancreatic function and diabetes (4 papers) and Mesenchymal stem cell research (3 papers). Weikai Hou is often cited by papers focused on Metabolism, Diabetes, and Cancer (5 papers), Pancreatic function and diabetes (4 papers) and Mesenchymal stem cell research (3 papers). Weikai Hou collaborates with scholars based in China and United States. Weikai Hou's co-authors include Li Chen, Yuxin Xu, Yu Sun, Lei Sun, Jun Song, Wen‐Wen Zhang, Kuanxiao Tang, Jianjun Dong, Bin Wang and Kexin Wang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Transplantation and Aging Clinical and Experimental Research.

In The Last Decade

Weikai Hou

19 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weikai Hou China 11 239 172 140 125 111 19 575
Jing Xue China 12 150 0.6× 186 1.1× 143 1.0× 115 0.9× 62 0.6× 33 594
Toru Tateno Japan 16 291 1.2× 162 0.9× 130 0.9× 156 1.2× 513 4.6× 32 745
Raquel Ferrer‐Lorente Spain 13 107 0.4× 370 2.2× 121 0.9× 108 0.9× 48 0.4× 22 684
Erika Hubina Hungary 10 261 1.1× 191 1.1× 44 0.3× 145 1.2× 404 3.6× 29 799
K.W. Annie Bang Canada 8 181 0.8× 211 1.2× 31 0.2× 61 0.5× 280 2.5× 11 665
László Bajnok Hungary 3 134 0.6× 587 3.4× 52 0.4× 164 1.3× 56 0.5× 14 844
Holger S. Willenberg Germany 15 307 1.3× 274 1.6× 37 0.3× 76 0.6× 340 3.1× 37 820
Megan Partyka United States 10 90 0.4× 167 1.0× 52 0.4× 65 0.5× 132 1.2× 13 605
Antonios Halapas Greece 13 160 0.7× 380 2.2× 31 0.2× 68 0.5× 216 1.9× 35 847
Michio Noguchi Japan 17 298 1.2× 463 2.7× 35 0.3× 90 0.7× 265 2.4× 34 904

Countries citing papers authored by Weikai Hou

Since Specialization
Citations

This map shows the geographic impact of Weikai Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weikai Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weikai Hou more than expected).

Fields of papers citing papers by Weikai Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weikai Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weikai Hou. The network helps show where Weikai Hou may publish in the future.

Co-authorship network of co-authors of Weikai Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Weikai Hou. A scholar is included among the top collaborators of Weikai Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weikai Hou. Weikai Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Jian, et al.. (2020). Ligliptin for treatment of type 2 diabetes mellitus with early renal injury: Efficacy and impact on endogenous hydrogen sulfide and endothelial function. World Journal of Clinical Cases. 8(10). 1878–1886. 3 indexed citations
2.
Guo, Jingjing, et al.. (2020). Risk factors for elevated serum colorectal cancer markers in patients with type 2 diabetes mellitus. Open Life Sciences. 15(1). 267–273. 1 indexed citations
3.
Zhou, Jian, Yaping Wei, Lan Yuan, et al.. (2019). Individual and joint association of bioavailable testosterone and aging with neutrophil-to-lymphocyte ratio in Chinese middle-aged and elderly men. Aging Clinical and Experimental Research. 32(8). 1515–1523. 10 indexed citations
4.
Wang, Kewei, Fuqiang Liu, Chuanlong Wu, et al.. (2018). Cyclic Cushing’s syndrome caused by neuroendocrine tumor: a case report. Endocrine Journal. 66(2). 175–180. 5 indexed citations
5.
Li, Xiuyun, et al.. (2018). The role of Keap1-Nrf2-ARE signal pathway in diabetic retinopathy oxidative stress and related mechanisms.. PubMed. 11(6). 3084–3090. 15 indexed citations
6.
Zhao, Ying, et al.. (2018). Hydroxysafflor yellow A attenuates high glucose-induced pancreatic β-cells oxidative damage via inhibiting JNK/c-jun signaling pathway. Biochemical and Biophysical Research Communications. 505(2). 353–359. 25 indexed citations
7.
Wang, Shuyan, et al.. (2016). A 3-year follow-up study of β-cell function in patients with early-onset type 2 diabetes. Experimental and Therapeutic Medicine. 12(2). 1097–1102. 10 indexed citations
8.
Wang, Kun, Li Zhang, Qingxian Huang, et al.. (2014). Epidemiological characteristics of thyroid nodules and risk factors for malignant nodules: a retrospective study from 6 304 surgical cases. Chinese Medical Journal. 127(12). 2286–2292. 14 indexed citations
9.
Liu, Qian, Li Zhang, Kun Wang, et al.. (2013). Effects of glucose and insulin on the H9c2 (2-1) cell proliferation may be mediated through regulating glucose transporter 4 expression. Chinese Medical Journal. 126(21). 4037–4042. 10 indexed citations
10.
Huang, Qingxian, Ping Wang, Qian Liu, et al.. (2013). Basal insulin therapy strategy is superior to premixed insulin therapy in the perioperative period blood glucose management. Chinese Medical Journal. 126(21). 4030–4036. 3 indexed citations
11.
Yu, Shan, Meizhen Li, Hua Xu, et al.. (2012). Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients.. Chinese Medical Journal. 125(19). 3440–4. 56 indexed citations
12.
Lai, Hong, et al.. (2011). [A genetic and clinical study in a family with familial hypercholesterolemia].. PubMed. 50(2). 120–3. 1 indexed citations
13.
Xu, Yuxin, L. Chen, Weikai Hou, et al.. (2009). Mesenchymal Stem Cells Treated With Rat Pancreatic Extract Secrete Cytokines That Improve the Glycometabolism of Diabetic Rats. Transplantation Proceedings. 41(5). 1878–1884. 20 indexed citations
14.
Zhang, Wenwen, Li Zhang, Weikai Hou, et al.. (2009). Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion.. PubMed. 122(17). 1996–2001. 27 indexed citations
15.
Chen, Li, Rong Wang, Weikai Hou, et al.. (2008). Mesenchymal stem cell therapy for diabetes through paracrine mechanisms. Medical Hypotheses. 71(3). 390–393. 47 indexed citations
16.
Chen, Lulu, Jianjun Dong, Weikai Hou, et al.. (2008). SUSTAINED EFFECT OF AUTOLOGOUS BONE MARROW MONONUCLEAR CELL TRANSPLANTATION IN PATIENTS WITH DIABETES 12 MONTH FOLLOW-UP. Transplantation. 86(2S). 162–162. 10 indexed citations
17.
Hou, Weikai, Li Zhang, Yuxin Xu, et al.. (2007). Influence of blood glucose on the expression of glucose transporter proteins 1 and 3 in the brain of diabetic rats. Chinese Medical Journal. 120(19). 1704–1709. 51 indexed citations
18.
Sun, Yu, Li Chen, Xinguo Hou, et al.. (2007). Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chinese Medical Journal. 120(9). 771–776. 153 indexed citations
19.
Hou, Weikai, Yuxin Xu, Ting Yu, et al.. (2007). Adipocytokines and breast cancer risk. Chinese Medical Journal. 120(18). 1592–1596. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jing Xue Breakdown of academic impact, for papers by Toru Tateno Breakdown of academic impact, for papers by Raquel Ferrer‐Lorente Breakdown of academic impact, for papers by Erika Hubina Breakdown of academic impact, for papers by K.W. Annie Bang Breakdown of academic impact, for papers by László Bajnok Breakdown of academic impact, for papers by Holger S. Willenberg Breakdown of academic impact, for papers by Megan Partyka Breakdown of academic impact, for papers by Antonios Halapas Breakdown of academic impact, for papers by Michio Noguchi
Rankless by CCL
2026